PMID- 7582467 OWN - NLM STAT- MEDLINE DCOM- 19951127 LR - 20190512 IS - 0007-1188 (Print) IS - 0007-1188 (Linking) VI - 115 IP - 3 DP - 1995 Jun TI - All-or-none augmentation of Ca2+ sensitivity in alpha-toxin-permeabilized single smooth muscle cells from guinea-pig taenia caecum. PG - 522-6 AB - 1. Isolated smooth muscle cells from guinea-pig taenia caecum were permeabilized by use of Staphylococcus aureus alpha-toxin, and the sarcoplasmic reticulum Ca2+ store was depleted by exposure to 0.1 microM A23187. 2. Shortening of alpha-toxin-permeabilized single smooth muscle cells was induced by increasing free Ca2+ but was not induced by 0.2 microM free Ca2+. 3. Shortening of the permeabilized cells was caused by application of acetylcholine (ACh) with free Ca2+ concentration held at 0.2 microM. Permeabilized smooth muscle cells responded to 0.3 microM or 1 microM ACh with 0.2 microM Ca2+ with maximal shortening. The concentration-response relationship to ACh had a very steep slope and the cell shortening appeared to be an all-or-none response rather than a graded response, as was the shortening of intact cells to ACh. 4. The shortening of permeabilized cells was also induced by application of guanosine 5'-triphosphate (GTP) with 0.2 microM free Ca2+, showing an all-or-none response. The threshold concentration of GTP that induced an all-or-none response was between 10 microM and 30 microM. 5. These results suggest that Ca2+ sensitivity is augmented by stimulation of the muscarinic receptor or GTP-binding protein(s) in an all-or-none manner. It seems probable that this contributes to the all-or-none response to ACh in intact smooth muscle cells. FAU - Mita, M AU - Mita M AD - Department of Pharmacology, Meiji College of Pharmacy, Tokyo, Japan. FAU - Hashimoto, T AU - Hashimoto T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Br J Pharmacol JT - British journal of pharmacology JID - 7502536 RN - 0 (Bacterial Toxins) RN - 0 (Hemolysin Proteins) RN - 0 (Ionophores) RN - 0 (Receptors, Muscarinic) RN - 0 (staphylococcal alpha-toxin) RN - 37H9VM9WZL (Calcimycin) RN - 86-01-1 (Guanosine Triphosphate) RN - EC 3.6.1.- (GTP-Binding Proteins) RN - N9YNS0M02X (Acetylcholine) RN - SY7Q814VUP (Calcium) SB - IM MH - Acetylcholine/pharmacology MH - Animals MH - Bacterial Toxins/*toxicity MH - Calcimycin/pharmacology MH - Calcium/*metabolism/pharmacology MH - Cecum/cytology/*drug effects MH - Cell Membrane Permeability/drug effects MH - Cell Size/drug effects MH - Cells, Cultured MH - GTP-Binding Proteins/drug effects/metabolism MH - Guanosine Triphosphate/pharmacology MH - Guinea Pigs MH - Hemolysin Proteins/*toxicity MH - Ionophores/pharmacology MH - Microscopy, Phase-Contrast MH - Muscle Contraction/drug effects MH - Muscle, Smooth/cytology/*drug effects MH - Receptors, Muscarinic/drug effects/metabolism MH - Sarcoplasmic Reticulum/drug effects/metabolism MH - *Staphylococcus aureus PMC - PMC1908411 EDAT- 1995/06/01 00:00 MHDA- 1995/06/01 00:01 PMCR- 1996/06/01 CRDT- 1995/06/01 00:00 PHST- 1995/06/01 00:00 [pubmed] PHST- 1995/06/01 00:01 [medline] PHST- 1995/06/01 00:00 [entrez] PHST- 1996/06/01 00:00 [pmc-release] AID - 10.1111/j.1476-5381.1995.tb16365.x [doi] PST - ppublish SO - Br J Pharmacol. 1995 Jun;115(3):522-6. doi: 10.1111/j.1476-5381.1995.tb16365.x.